Thermo Fisher Scientific’s therapeutics supply team enables our partners to develop and commercialize therapeutic solutions through strategic relationships. Integrating our platform technologies, products, capabilities, and intellectual property, together we can accelerate the delivery of next-generation therapeutics to market.

We offer an extensive portfolio of novel workflow solutions for:

  • Cell and gene therapy
  • Protein therapeutics
  • DNA and RNA therapeutics

To learn more about our partnering opportunities or to speak with a therapeutic portfolio specialist, please submit an inquiry below.

Submit an inquiry ›


Cell and gene therapy

We’re uniquely positioned to address the specific needs of the cell therapy market through integrated solutions that help your process development reach high quality manufacturing.

Application-driven media development service

  • Serum replacement

Cell isolation, activation, and expansion

  • Dynabeads™ CD3/CD28
  • Application-drive custom Dynabeads™ development service 

Cell engineering

  • TALEN™-based genome editing 

Ex vivo and in vivo gene delivery

  • Vector production solutions
  • Lipofectamine™ transfection agents
  • Invivofectamine™ Rx lipid nanoparticle technology


Protein therapeutics 

We possess a breadth of host cells, cell engineering, and protein expression tools and technologies to assist your protein therapeutic development and commercialization.  

GMP cell lines

  • Freedom™ CHO-S
  • DG44

Non-GMP cell lines

  • HEK-293
  • Sf-9
  • Expi293™
  • ExpiCHO™

Cell culture media

  • Custom manufacturing
  • Classical media
  • Reagents/supplements

Cell engineering

  • TALEN™-based genome editing
  • CRISPR-Cas9 genome editing

Transfection agents

  • Lipofectamine™ 2000 and 3000


DNA and RNA therapeutics

Thermo Fisher Scientific enables your entire DNA and RNA therapeutic development, manufacturing workflow from molecule synthesis, purification and analysis, and formulation and delivery. 

Purification and analysis

  • Dynabeads™ Oligo (dT)25

Nucleic acid synthesis

  • Enzymes (e.g. capping, 2’-O-Methyltransferase), T7 RNA polymerase, poly A polymerase, etc.)
  • Nucleotides (NTPs, modified NTPs)
  • Stabilization molecules (ARCA, CAP analogs)
  • Accessory enzymes (RNAse inhibitor, inorganic pyrophosphatase, DNAse I)
  • Buffers
  • Phosphoramidites (DNA, RNA, modified, linkers, and spacers)
  • Solid supports

Formulation and delivery

  • Invivofectamine™ Rx lipid nanoparticle technology
  • Scalable platform
  • Proprietary lipid library
  • Optimized formulation for in vivo delivery 

UX DATA-TRKR Retired - Admins, feel free to remove this reference component.